PDS Biotechnology
PDSB
NZ$2.19
Share price
4.72%
Change (1 day)
-55.50%
Change (1 year)
Categories
PDS Biotechnology (PDSB) - Total liabilities
Total liabilities on the balance sheet as of March 2025 : NZ$40.63 Million
According to PDS Biotechnology 's latest financial reports the company's total liabilities are NZ$40.63 Million. A company’s total liabilities is the sum of all current and non-current debts and obligations.
PDS Biotechnology - Total liabilities on balance sheet (from 2014 to 2025)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023-12-31 | NZ$52.59 M | 1.17% |
| 2022-12-31 | NZ$51.98 M | 790.51% |
| 2021-12-31 | NZ$5.83 M | 12% |
| 2020-12-31 | NZ$5.21 M | 25.66% |
| 2019-12-31 | NZ$4.14 M | -56.4% |
| 2018-12-31 | NZ$9.51 M | -77.66% |
| 2017-12-31 | NZ$42.59 M | 36.35% |
| 2016-12-31 | NZ$31.23 M | 84.07% |
| 2015-12-31 | NZ$16.97 M | -70.24% |
| 2014-12-31 | NZ$57.02 M | 94.58% |
| 2013-12-31 | NZ$29.3 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | NZ$38.08 M | -6.27% | 🇺🇸 USA |